Taigo Kato, MD, PhD, discusses the use of ctDNA-guided therapy in patients with RCC.
Taigo Kato, MD, PhD
Advertisement
Taigo Kato, MD, PhD, is an assistant professor in the Department of Urology at Osaka University Graduate School of Medicine.
Articles by Taigo Kato, MD, PhD
Taigo Kato, MD, PhD, discusses future directions of MONSTAR-SCREEN-3 and how data from the study can be applied to clinical practice.
Taigo Kato, MD, PhD, discusses the background of the MONSTAR-SCREEN-3 in resectable RCC and the key findings from the study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
2
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
5